Literature DB >> 17442615

Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H.

Fumitaka Suzuki1, Norio Akuta, Yoshiyuki Suzuki, Hiromi Yatsuji, Hitomi Sezaki, Yasuji Arase, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki, Hiromitsu Kumada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17442615     DOI： 10.1016/j.jcv.2007.03.004

Source DB:  PubMed          Journal:  J Clin Virol        ISSN： 1386-6532            Impact factor:   3.168


× No keyword cloud information.
  7 in total

1.  Acute hepatitis B of genotype H resulting in persistent infection.

Authors:  Norie Yamada; Ryuta Shigefuku; Ryuichi Sugiyama; Minoru Kobayashi; Hiroki Ikeda; Hideaki Takahashi; Chiaki Okuse; Michihiro Suzuki; Fumio Itoh; Hiroshi Yotsuyanagi; Kiyomi Yasuda; Kyoji Moriya; Kazuhiko Koike; Takaji Wakita; Takanobu Kato
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus.

Authors:  Julie Sheldon; Nathan M Beach; Elena Moreno; Isabel Gallego; David Piñeiro; Encarnación Martínez-Salas; Josep Gregori; Josep Quer; Juan Ignacio Esteban; Charles M Rice; Esteban Domingo; Celia Perales
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

3.  Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure.

Authors:  Stephen Locarnini
Journal:  Hepatol Int       Date:  2008-03-28       Impact factor: 6.047

4.  Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B.

Authors:  Haruhiko Kobashi; Shin-Ichi Fujioka; Mitsuhiko Kawaguchi; Hiromitsu Kumada; Osamu Yokosuka; Norio Hayashi; Kazuyuki Suzuki; Takeshi Okanoue; Michio Sata; Hirohito Tsubouchi; Chifumi Sato; Kendo Kiyosawa; Kyuichi Tanikawa; Taku Seriu; Hiroki Ishikawa; Akinobu Takaki; Yoshiaki Iwasaki; Toshiya Osawa; Toshiyuki Takaki; Kosaku Sakaguchi; Yasushi Shiratori; Kazuhide Yamamoto; Daniel J Tenney; Masao Omata
Journal:  Hepatol Int       Date:  2008-12-09       Impact factor: 6.047

Review 5.  Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.

Authors:  Zhuo-Lun Song; Yu-Jun Cui; Wei-Ping Zheng; Da-Hong Teng; Hong Zheng
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

6.  Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan.

Authors:  Fumitaka Suzuki; Tetsuya Hosaka; Yoshiyuki Suzuki; Hitomi Sezaki; Norio Akuta; Shunichiro Fujiyama; Yusuke Kawamura; Masahiro Kobayashi; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Mariko Kobayashi; Rie Mineta; Yukiko Suzuki; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2018-08-22       Impact factor: 6.772

7.  Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?

Authors:  Joon Yeul Nam; Jeong-Hoon Lee
Journal:  Clin Mol Hepatol       Date:  2017-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.